Downstream processing operations, specifically the bottlenecks they create in the biomanufacturing process, are one area where disruptive innovation is starting to be applied.

When asked what downstream challenges now face biomanufacturers as biologics complexity grows, Ghose replied that the major challenge is likely to be the increased burden and diversity of process ...